Breaking News Instant updates and real-time market news.

IMMP

Immutep

$1.70

(0.00%)

08:22
07/09/19
07/09
08:22
07/09/19
08:22

Immutep raises A$10M via private placement, underwritten entitlement offer

Immutep has announced an equity financing to raise gross proceeds of approximately A$10M, or $7M comprising the following: a private placement of 190.5 million new fully paid ordinary shares in the Company to multiple new and existing Australian and other institutional and professional investors at an issue price of A$0.021 per Share, raising a total of A$4M before transaction-related expenses; and a 1 for 11.8 fully underwritten pro rata non-renounceable entitlement offer of new Shares at the Offer Price to raise approximately A$6M. Only persons holding ordinary shares of the Company and having a registered address in Australia or New Zealand are entitled to participate in the Entitlement Offer. U.S. persons who own, directly or indirectly, ordinary shares or American Depositary Shares of the Company may not participate in the Entitlement Offer. These capital raising transactions are subject to customary closing conditions in Australia. Settlement of the Shares in the Private Placement is expected to occur on July 16, 2019 and in the Entitlement Offer in early August 2019. The Company will use the proceeds received from the Private Placement and the Entitlement Offer to finance its LAG-3 related clinical program in immuno-oncology and autoimmune disease. This includes the ongoing clinical development of eftilagimod alpha, via its TACTI-mel, TACTI-002, and INSIGHT clinical studies, development of IMP761 and for general corporate purposes. Subject to sufficient and clinically meaningful data from the Company's most advanced and potentially pivotal clinical trial, AIPAC, the funds raised may also be applied to pursue the appropriate regulatory pathways for efti and to explore ways to bridge Immutep's research efforts in metastatic breast cancer to the United States.

IMMP Immutep
$1.70

(0.00%)

09/28/18
RILY
09/28/18
INITIATION
Target $7.75
RILY
Buy
Immutep initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Dylan Dupuis started Immutep with a Buy rating and $7.75 price target. The analyst views the company as a leader in LAG-3 immunotheraphy.

TODAY'S FREE FLY STORIES

KBR

KBR

$25.28

0.36 (1.44%)

07:01
07/19/19
07/19
07:01
07/19/19
07:01
Upgrade
KBR rating change  »

KBR upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

ROK

Rockwell Automation

$159.17

-0.78 (-0.49%)

07:00
07/19/19
07/19
07:00
07/19/19
07:00
Recommendations
Rockwell Automation analyst commentary  »

JPMorgan's Tusa says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

SXT

Sensient

$70.77

-0.48 (-0.67%)

07:00
07/19/19
07/19
07:00
07/19/19
07:00
Earnings
Sensient lowers 2019 adjusted EPS view to down 8%-9% from down 4%-7% »

Consensus for 2019 EPS is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

MSFT

Microsoft

$136.29

0.06 (0.04%)

06:58
07/19/19
07/19
06:58
07/19/19
06:58
Recommendations
Microsoft analyst commentary  »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

BLK

BlackRock

$474.98

4.06 (0.86%)

06:58
07/19/19
07/19
06:58
07/19/19
06:58
Hot Stocks
BlackRock CEO: Trend in China continues to be downward »

Says: Companies are not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Oct

MSFT

Microsoft

$136.29

0.06 (0.04%)

06:57
07/19/19
07/19
06:57
07/19/19
06:57
Recommendations
Microsoft analyst commentary  »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

CNK

Cinemark

$36.46

-1.31 (-3.47%)

06:57
07/19/19
07/19
06:57
07/19/19
06:57
Initiation
Cinemark initiated  »

Cinemark initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SXT

Sensient

$70.77

-0.48 (-0.67%)

06:56
07/19/19
07/19
06:56
07/19/19
06:56
Earnings
Sensient reports Q2 EPS 81c, consensus 82c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

EYE

National Vision

$32.05

0.35 (1.10%)

06:56
07/19/19
07/19
06:56
07/19/19
06:56
Hot Stocks
National Vision names Melissa Rasmussen as Chief Accounting Officer »

National Vision announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$72.75

1.77 (2.49%)

06:55
07/19/19
07/19
06:55
07/19/19
06:55
Recommendations
Crowdstrike analyst commentary  »

Crowdstrike price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDFN

Redfin

$16.84

-0.74 (-4.21%)

06:54
07/19/19
07/19
06:54
07/19/19
06:54
Initiation
Redfin initiated  »

Redfin initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

LYB

LyondellBasell

$85.70

-0.03 (-0.03%)

06:52
07/19/19
07/19
06:52
07/19/19
06:52
Initiation
LyondellBasell initiated  »

LyondellBasell reinstated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Z

Zillow

$48.20

0.08 (0.17%)

06:51
07/19/19
07/19
06:51
07/19/19
06:51
Initiation
Zillow initiated  »

Zillow initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

MSFT

Microsoft

$136.29

0.06 (0.04%)

06:49
07/19/19
07/19
06:49
07/19/19
06:49
Recommendations
Microsoft analyst commentary  »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

BLK

BlackRock

$474.98

4.06 (0.86%)

06:48
07/19/19
07/19
06:48
07/19/19
06:48
Hot Stocks
BlackRock CEO: People are underinvested in equities »

Says: Markets will trend…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Oct

ATHM

Autohome

$82.03

-0.91 (-1.10%)

06:48
07/19/19
07/19
06:48
07/19/19
06:48
Downgrade
Autohome rating change  »

Autohome downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$38.78

0.15 (0.39%)

06:48
07/19/19
07/19
06:48
07/19/19
06:48
Hot Stocks
Schlumberger names Olivier Le Peuch as CEO, succeeding Paal Kibsgaard »

Schlumberger announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Aug

  • 13

    Nov

NWSA

News Corp.

$13.28

0.06 (0.45%)

06:47
07/19/19
07/19
06:47
07/19/19
06:47
Downgrade
News Corp. rating change  »

JPMorgan downgrades News…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$38.78

0.15 (0.39%)

06:46
07/19/19
07/19
06:46
07/19/19
06:46
Hot Stocks
Breaking Hot Stocks news story on Schlumberger »

Schlumberger names…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Aug

  • 13

    Nov

MSGN

MSG Networks

$20.22

-0.31 (-1.51%)

06:43
07/19/19
07/19
06:43
07/19/19
06:43
Downgrade
MSG Networks rating change  »

MSG Networks downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$72.75

1.77 (2.49%)

06:39
07/19/19
07/19
06:39
07/19/19
06:39
Recommendations
Crowdstrike analyst commentary  »

Crowdstrike price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFG

Citizens Financial

$34.62

0.27 (0.79%)

06:39
07/19/19
07/19
06:39
07/19/19
06:39
Hot Stocks
Citizens Financial increases dividend 13% to 36c per share »

Citizens Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

MSFT

Microsoft

$136.29

0.06 (0.04%)

06:38
07/19/19
07/19
06:38
07/19/19
06:38
Recommendations
Microsoft analyst commentary  »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

CFG

Citizens Financial

$34.62

0.27 (0.79%)

06:36
07/19/19
07/19
06:36
07/19/19
06:36
Earnings
Citizens Financial reports Q2 EPS 96c, consensus 94c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

TSLA

Tesla

$253.82

-1.03 (-0.40%)

06:35
07/19/19
07/19
06:35
07/19/19
06:35
Recommendations
Tesla analyst commentary  »

Barclays forecasts much…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 06

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.